Home/ Stocks/ MRK

Merck & Co., Inc.

MRK XNYS

$116.37 +1.00 (+0.86%) ▲ 15-min delayed

Open

$114.70

High

$116.54

Low

$114.02

Volume

7.41M

Market Cap

$286.01B

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 75.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$65.01B	$18.26B	$7.30
FY 2025	$65.01B	$18.26B	$7.30
Q3 2025	$17.28B	$5.79B	$2.32
Q2 2025	$15.81B	$4.43B	$1.76

Related Market News

No specific coverage for MRK yet. Check out our latest market news or earnings calendar.

Get MRK Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Merck & Co., Inc..

Related Stocks

UNH JNJ LLY PFE ABBV

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.